17190 Bernardo Center Drive
15 articles with BioMed Realty
BioMed Realty, a leading provider of real estate solutions to the life science community, has relocated their headquarters to discover@UTC at University Towne Centre, a campus the company has assembled and transformed over the last several years into a premier life science park in one of the top biotech markets in the country.
BioMed Realty announced today they have been awarded a Deal of the Year Award for their Zymergen lease at Emeryville Center of Innovation, presented by the San Francisco Business Times. Additionally, BioMed Realty’s President and CEO Tim Schoen has been recognized as the Dealmaker of the Year . This press release features multimedia. View the full r
BioMed Realty Strengthens World-Class Life Science Real Estate Platform With Officer Promotions in Its Core Markets
Veteran leasing, development, and legal professionals recognized for significant contributions
Another S&P 500 Life Science Enterprise to Occupy BioMed Realty’s Landmark Campus
Amgen Signs Lease With Biomed Realty for New Gateway of Pacific Campus Facility
BioMed Realty recently completed another project in the UTC area and opened the Center for Novel Therapeutics (“CNT”) on the campus of the University of California San Diego
BioMed Realty Announces 300,000 Square Feet Long-term Lease at Emeryville Center of Innovation Campus
Zymergen Signing Reinforces BioMed Realty’s Growth in the San Francisco Bay Area
BioMed Realty and University of California San Diego Celebrate Grand Opening of the Center for Novel Therapeutics
The Research Hub Includes the First Academic-Industry Drug Discovery Incubator in San Diego
BioMed Realty Launches The Second Phase At Gateway of Pacific - Expanding Its Landmark Campus At The Front Door Of San Francisco's Premier Life Science Market
BioMed Realty also closes a $430 million financing on the first phase of Gateway of Pacific after executing a long-term lease with AbbVie Inc. for 480,000 square feet
BioMed Realty Expands Life Science Footprint In San Francisco Bay Area With Campus Acquisition Of The Emeryville Center for Innovation
BioMed Realty, a Blackstone portfolio company, announced today the acquisition of the Emeryville Center for Innovation, located in Emeryville, California, for approximately $135 million.
In what appears to be a trend, big pharma company AbbVie is leasing 479,000 square feet of space inBioMed Realty’s Gateway of Pacific project in South San Francisco.
BioMed Realty Invests In The Construction Of Laboratory And Office Facilities At The Babraham Research Campus, Cambridge, U.K.
BioMed Realty And University of California, San Diego (UCSD) Announce Development Of New Global Center For Oncology Research